The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hepatitis B Vaccines Market Research Report 2024
Synopsis
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
The global Hepatitis B Vaccines market was valued at US$ 1021.8 million in 2023 and is anticipated to reach US$ 1159.5 million by 2030, witnessing a CAGR of 1.8% during the forecast period 2024-2030.
In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.
The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.
Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines.
Report Scope
The Hepatitis B Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Segment by Type
Yeast Derived
CHO Derived
Segment by Application
Children
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis B Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
The global Hepatitis B Vaccines market was valued at US$ 1021.8 million in 2023 and is anticipated to reach US$ 1159.5 million by 2030, witnessing a CAGR of 1.8% during the forecast period 2024-2030.
In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.
The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.
Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines.
Report Scope
The Hepatitis B Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Segment by Type
Yeast Derived
CHO Derived
Segment by Application
Children
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis B Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hepatitis B Vaccines Market Overview
1.1 Product Overview and Scope of Hepatitis B Vaccines
1.2 Hepatitis B Vaccines Segment by Type
1.2.1 Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Hepatitis B Vaccines Segment by Application
1.3.1 Global Hepatitis B Vaccines Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Adult
1.4 Global Hepatitis B Vaccines Market Size Estimates and Forecasts
1.4.1 Global Hepatitis B Vaccines Revenue 2019-2030
1.4.2 Global Hepatitis B Vaccines Sales 2019-2030
1.4.3 Global Hepatitis B Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hepatitis B Vaccines Market Competition by Manufacturers
2.1 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hepatitis B Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Hepatitis B Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis B Vaccines, Product Type & Application
2.7 Hepatitis B Vaccines Market Competitive Situation and Trends
2.7.1 Hepatitis B Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hepatitis B Vaccines Players Market Share by Revenue
2.7.3 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis B Vaccines Retrospective Market Scenario by Region
3.1 Global Hepatitis B Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hepatitis B Vaccines Global Hepatitis B Vaccines Sales by Region: 2019-2030
3.2.1 Global Hepatitis B Vaccines Sales by Region: 2019-2024
3.2.2 Global Hepatitis B Vaccines Sales by Region: 2025-2030
3.3 Global Hepatitis B Vaccines Global Hepatitis B Vaccines Revenue by Region: 2019-2030
3.3.1 Global Hepatitis B Vaccines Revenue by Region: 2019-2024
3.3.2 Global Hepatitis B Vaccines Revenue by Region: 2025-2030
3.4 North America Hepatitis B Vaccines Market Facts & Figures by Country
3.4.1 North America Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hepatitis B Vaccines Sales by Country (2019-2030)
3.4.3 North America Hepatitis B Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hepatitis B Vaccines Market Facts & Figures by Country
3.5.1 Europe Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hepatitis B Vaccines Sales by Country (2019-2030)
3.5.3 Europe Hepatitis B Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis B Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hepatitis B Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Hepatitis B Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hepatitis B Vaccines Market Facts & Figures by Country
3.7.1 Latin America Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hepatitis B Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Hepatitis B Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis B Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hepatitis B Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hepatitis B Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis B Vaccines Sales by Type (2019-2030)
4.1.1 Global Hepatitis B Vaccines Sales by Type (2019-2024)
4.1.2 Global Hepatitis B Vaccines Sales by Type (2025-2030)
4.1.3 Global Hepatitis B Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Hepatitis B Vaccines Revenue by Type (2019-2030)
4.2.1 Global Hepatitis B Vaccines Revenue by Type (2019-2024)
4.2.2 Global Hepatitis B Vaccines Revenue by Type (2025-2030)
4.2.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Hepatitis B Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hepatitis B Vaccines Sales by Application (2019-2030)
5.1.1 Global Hepatitis B Vaccines Sales by Application (2019-2024)
5.1.2 Global Hepatitis B Vaccines Sales by Application (2025-2030)
5.1.3 Global Hepatitis B Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Hepatitis B Vaccines Revenue by Application (2019-2030)
5.2.1 Global Hepatitis B Vaccines Revenue by Application (2019-2024)
5.2.2 Global Hepatitis B Vaccines Revenue by Application (2025-2030)
5.2.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Hepatitis B Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Hepatitis B Vaccines Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 NCPC
6.2.1 NCPC Corporation Information
6.2.2 NCPC Description and Business Overview
6.2.3 NCPC Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 NCPC Hepatitis B Vaccines Product Portfolio
6.2.5 NCPC Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Hepatitis B Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Bio Kangtai
6.4.1 Bio Kangtai Corporation Information
6.4.2 Bio Kangtai Description and Business Overview
6.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio Kangtai Hepatitis B Vaccines Product Portfolio
6.4.5 Bio Kangtai Recent Developments/Updates
6.5 Dynavax
6.5.1 Dynavax Corporation Information
6.5.2 Dynavax Description and Business Overview
6.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dynavax Hepatitis B Vaccines Product Portfolio
6.5.5 Dynavax Recent Developments/Updates
6.6 Hissen
6.6.1 Hissen Corporation Information
6.6.2 Hissen Description and Business Overview
6.6.3 Hissen Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hissen Hepatitis B Vaccines Product Portfolio
6.6.5 Hissen Recent Developments/Updates
6.7 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KM Biologics Hepatitis B Vaccines Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 LG Life Sciences
6.8.1 LG Life Sciences Corporation Information
6.8.2 LG Life Sciences Description and Business Overview
6.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 LG Life Sciences Hepatitis B Vaccines Product Portfolio
6.8.5 LG Life Sciences Recent Developments/Updates
6.9 Serum Institute
6.9.1 Serum Institute Corporation Information
6.9.2 Serum Institute Description and Business Overview
6.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Serum Institute Hepatitis B Vaccines Product Portfolio
6.9.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis B Vaccines Industry Chain Analysis
7.2 Hepatitis B Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis B Vaccines Production Mode & Process
7.4 Hepatitis B Vaccines Sales and Marketing
7.4.1 Hepatitis B Vaccines Sales Channels
7.4.2 Hepatitis B Vaccines Distributors
7.5 Hepatitis B Vaccines Customers
8 Hepatitis B Vaccines Market Dynamics
8.1 Hepatitis B Vaccines Industry Trends
8.2 Hepatitis B Vaccines Market Drivers
8.3 Hepatitis B Vaccines Market Challenges
8.4 Hepatitis B Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hepatitis B Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hepatitis B Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hepatitis B Vaccines Sales (M Doses) of Key Manufacturers (2019-2024)
Table 5. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hepatitis B Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hepatitis B Vaccines Average Price (USD/Doses) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hepatitis B Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatitis B Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Hepatitis B Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses)
Table 18. Global Hepatitis B Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses)
Table 20. Global Hepatitis B Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hepatitis B Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hepatitis B Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 27. North America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 28. North America Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 32. Europe Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 33. Europe Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hepatitis B Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses)
Table 37. Asia Pacific Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses)
Table 38. Asia Pacific Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 42. Latin America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 43. Latin America Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 47. Middle East & Africa Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 48. Middle East & Africa Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hepatitis B Vaccines Sales (M Doses) by Type (2019-2024)
Table 51. Global Hepatitis B Vaccines Sales (M Doses) by Type (2025-2030)
Table 52. Global Hepatitis B Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Hepatitis B Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Hepatitis B Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hepatitis B Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Hepatitis B Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2019-2024)
Table 59. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2025-2030)
Table 60. Global Hepatitis B Vaccines Sales (M Doses) by Application (2019-2024)
Table 61. Global Hepatitis B Vaccines Sales (M Doses) by Application (2025-2030)
Table 62. Global Hepatitis B Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Hepatitis B Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Hepatitis B Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hepatitis B Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Hepatitis B Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2019-2024)
Table 69. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 73. GSK Hepatitis B Vaccines Product
Table 74. GSK Recent Developments/Updates
Table 75. NCPC Corporation Information
Table 76. NCPC Description and Business Overview
Table 77. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 78. NCPC Hepatitis B Vaccines Product
Table 79. NCPC Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 83. Merck Hepatitis B Vaccines Product
Table 84. Merck Recent Developments/Updates
Table 85. Bio Kangtai Corporation Information
Table 86. Bio Kangtai Description and Business Overview
Table 87. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 88. Bio Kangtai Hepatitis B Vaccines Product
Table 89. Bio Kangtai Recent Developments/Updates
Table 90. Dynavax Corporation Information
Table 91. Dynavax Description and Business Overview
Table 92. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 93. Dynavax Hepatitis B Vaccines Product
Table 94. Dynavax Recent Developments/Updates
Table 95. Hissen Corporation Information
Table 96. Hissen Description and Business Overview
Table 97. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 98. Hissen Hepatitis B Vaccines Product
Table 99. Hissen Recent Developments/Updates
Table 100. KM Biologics Corporation Information
Table 101. KM Biologics Description and Business Overview
Table 102. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 103. KM Biologics Hepatitis B Vaccines Product
Table 104. KM Biologics Recent Developments/Updates
Table 105. LG Life Sciences Corporation Information
Table 106. LG Life Sciences Description and Business Overview
Table 107. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 108. LG Life Sciences Hepatitis B Vaccines Product
Table 109. LG Life Sciences Recent Developments/Updates
Table 110. Serum Institute Corporation Information
Table 111. Serum Institute Description and Business Overview
Table 112. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 113. Serum Institute Hepatitis B Vaccines Product
Table 114. Serum Institute Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Hepatitis B Vaccines Distributors List
Table 118. Hepatitis B Vaccines Customers List
Table 119. Hepatitis B Vaccines Market Trends
Table 120. Hepatitis B Vaccines Market Drivers
Table 121. Hepatitis B Vaccines Market Challenges
Table 122. Hepatitis B Vaccines Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis B Vaccines
Figure 2. Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hepatitis B Vaccines Market Share by Type in 2023 & 2030
Figure 4. Yeast Derived Product Picture
Figure 5. CHO Derived Product Picture
Figure 6. Global Hepatitis B Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hepatitis B Vaccines Market Share by Application in 2023 & 2030
Figure 8. Children
Figure 9. Adult
Figure 10. Global Hepatitis B Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Hepatitis B Vaccines Market Size (2019-2030) & (US$ Million)
Figure 12. Global Hepatitis B Vaccines Sales (2019-2030) & (M Doses)
Figure 13. Global Hepatitis B Vaccines Average Price (USD/Doses) & (2019-2030)
Figure 14. Hepatitis B Vaccines Report Years Considered
Figure 15. Hepatitis B Vaccines Sales Share by Manufacturers in 2023
Figure 16. Global Hepatitis B Vaccines Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Hepatitis B Vaccines Players: Market Share by Revenue in 2023
Figure 18. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
Figure 21. North America Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
Figure 25. Europe Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
Figure 26. Germany Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Region (2019-2030)
Figure 33. China Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
Figure 44. Latin America Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Hepatitis B Vaccines by Type (2019-2030)
Figure 54. Global Revenue Market Share of Hepatitis B Vaccines by Type (2019-2030)
Figure 55. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2019-2030)
Figure 56. Global Sales Market Share of Hepatitis B Vaccines by Application (2019-2030)
Figure 57. Global Revenue Market Share of Hepatitis B Vaccines by Application (2019-2030)
Figure 58. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2019-2030)
Figure 59. Hepatitis B Vaccines Value Chain
Figure 60. Hepatitis B Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
